Ushanti Colour Chem Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: July 9, 2025, 11:57 am

Competitors of Ushanti Colour Chem Ltd

All Competitor Stocks of Ushanti Colour Chem Ltd

Quarterly Result

Last Updated: May 31, 2025, 7:24 am

Below is a detailed analysis of the quarterly data for Ushanti Colour Chem Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 41.13 Cr.. The value appears strong and on an upward trend. It has increased from 36.92 Cr. (Sep 2024) to 41.13 Cr., marking an increase of 4.21 Cr..
• For Expenses, as of Mar 2025, the value is 40.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 36.36 Cr. (Sep 2024) to 40.00 Cr., marking an increase of 3.64 Cr..
• For Operating Profit, as of Mar 2025, the value is 1.13 Cr.. The value appears strong and on an upward trend. It has increased from 0.56 Cr. (Sep 2024) to 1.13 Cr., marking an increase of 0.57 Cr..
• For OPM %, as of Mar 2025, the value is 2.75%. The value appears strong and on an upward trend. It has increased from 1.52% (Sep 2024) to 2.75%, marking an increase of 1.23%.
• For Other Income, as of Mar 2025, the value is 0.66 Cr.. The value appears to be declining and may need further review. It has decreased from 0.81 Cr. (Sep 2024) to 0.66 Cr., marking a decrease of 0.15 Cr..
• For Interest, as of Mar 2025, the value is 3.01 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.24 Cr. (Sep 2024) to 3.01 Cr., marking an increase of 0.77 Cr..
• For Depreciation, as of Mar 2025, the value is 2.10 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.96 Cr. (Sep 2024) to 2.10 Cr., marking an increase of 0.14 Cr..
• For Profit before tax, as of Mar 2025, the value is -3.32 Cr.. The value appears to be declining and may need further review. It has decreased from -2.83 Cr. (Sep 2024) to -3.32 Cr., marking a decrease of 0.49 Cr..
• For Tax %, as of Mar 2025, the value is 17.77%. The value appears to be increasing, which may not be favorable. It has increased from 9.54% (Sep 2024) to 17.77%, marking an increase of 8.23%.
• For Net Profit, as of Mar 2025, the value is -3.91 Cr.. The value appears to be declining and may need further review. It has decreased from -3.11 Cr. (Sep 2024) to -3.91 Cr., marking a decrease of 0.80 Cr..
• For EPS in Rs, as of Mar 2025, the value is -1.34. The value appears to be declining and may need further review. It has decreased from -1.01 (Sep 2024) to -1.34, marking a decrease of 0.33.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 3:34 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 11:08 am

Below is a detailed analysis of the balance sheet data for Ushanti Colour Chem Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 11.24 Cr.. The value appears strong and on an upward trend. It has increased from 10.70 Cr. (Mar 2024) to 11.24 Cr., marking an increase of 0.54 Cr..
• For Reserves, as of Mar 2025, the value is 33.26 Cr.. The value appears to be declining and may need further review. It has decreased from 33.61 Cr. (Mar 2024) to 33.26 Cr., marking a decrease of 0.35 Cr..
• For Borrowings, as of Mar 2025, the value is 56.69 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 51.56 Cr. (Mar 2024) to 56.69 Cr., marking an increase of 5.13 Cr..
• For Other Liabilities, as of Mar 2025, the value is 18.09 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 13.42 Cr. (Mar 2024) to 18.09 Cr., marking an increase of 4.67 Cr..
• For Total Liabilities, as of Mar 2025, the value is 119.28 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 109.29 Cr. (Mar 2024) to 119.28 Cr., marking an increase of 9.99 Cr..
• For Fixed Assets, as of Mar 2025, the value is 62.00 Cr.. The value appears to be declining and may need further review. It has decreased from 63.91 Cr. (Mar 2024) to 62.00 Cr., marking a decrease of 1.91 Cr..
• For CWIP, as of Mar 2025, the value is 1.55 Cr.. The value appears strong and on an upward trend. It has increased from 0.48 Cr. (Mar 2024) to 1.55 Cr., marking an increase of 1.07 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 55.73 Cr.. The value appears strong and on an upward trend. It has increased from 44.90 Cr. (Mar 2024) to 55.73 Cr., marking an increase of 10.83 Cr..
• For Total Assets, as of Mar 2025, the value is 119.28 Cr.. The value appears strong and on an upward trend. It has increased from 109.29 Cr. (Mar 2024) to 119.28 Cr., marking an increase of 9.99 Cr..

However, the Borrowings (56.69 Cr.) are higher than the Reserves (₹33.26 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Ushanti Colour Chem Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is -2.43. This value is below the healthy minimum of 5. It has increased from -2.47 (Mar 24) to -2.43, marking an increase of 0.04.
• For Diluted EPS (Rs.), as of Mar 25, the value is -2.43. This value is below the healthy minimum of 5. It has increased from -2.47 (Mar 24) to -2.43, marking an increase of 0.04.
• For Cash EPS (Rs.), as of Mar 25, the value is -2.62. This value is below the healthy minimum of 3. It has decreased from -1.53 (Mar 24) to -2.62, marking a decrease of 1.09.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 39.59. It has decreased from 41.21 (Mar 24) to 39.59, marking a decrease of 1.62.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 39.59. It has decreased from 41.21 (Mar 24) to 39.59, marking a decrease of 1.62.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 69.46. It has increased from 47.38 (Mar 24) to 69.46, marking an increase of 22.08.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 2.81. This value is within the healthy range. It has decreased from 2.87 (Mar 24) to 2.81, marking a decrease of 0.06.
• For PBIT / Share (Rs.), as of Mar 25, the value is -0.80. This value is below the healthy minimum of 0. It has decreased from -0.05 (Mar 24) to -0.80, marking a decrease of 0.75.
• For PBT / Share (Rs.), as of Mar 25, the value is -5.48. This value is below the healthy minimum of 0. It has decreased from -2.90 (Mar 24) to -5.48, marking a decrease of 2.58.
• For Net Profit / Share (Rs.), as of Mar 25, the value is -6.24. This value is below the healthy minimum of 2. It has decreased from -4.45 (Mar 24) to -6.24, marking a decrease of 1.79.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -2.35. This value is below the healthy minimum of 2. It has increased from -2.42 (Mar 24) to -2.35, marking an increase of 0.07.
• For PBDIT Margin (%), as of Mar 25, the value is 4.04. This value is below the healthy minimum of 10. It has decreased from 6.05 (Mar 24) to 4.04, marking a decrease of 2.01.
• For PBIT Margin (%), as of Mar 25, the value is -1.15. This value is below the healthy minimum of 10. It has decreased from -0.11 (Mar 24) to -1.15, marking a decrease of 1.04.
• For PBT Margin (%), as of Mar 25, the value is -7.88. This value is below the healthy minimum of 10. It has decreased from -6.12 (Mar 24) to -7.88, marking a decrease of 1.76.
• For Net Profit Margin (%), as of Mar 25, the value is -8.98. This value is below the healthy minimum of 5. It has increased from -9.40 (Mar 24) to -8.98, marking an increase of 0.42.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is -3.38. This value is below the healthy minimum of 8. It has increased from -5.11 (Mar 24) to -3.38, marking an increase of 1.73.
• For Return on Networth / Equity (%), as of Mar 25, the value is -5.93. This value is below the healthy minimum of 15. It has decreased from -5.85 (Mar 24) to -5.93, marking a decrease of 0.08.
• For Return on Capital Employeed (%), as of Mar 25, the value is -1.42. This value is below the healthy minimum of 10. It has decreased from -0.08 (Mar 24) to -1.42, marking a decrease of 1.34.
• For Return On Assets (%), as of Mar 25, the value is -2.21. This value is below the healthy minimum of 5. It has increased from -2.37 (Mar 24) to -2.21, marking an increase of 0.16.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.49. This value is within the healthy range. It has decreased from 0.57 (Mar 24) to 0.49, marking a decrease of 0.08.
• For Total Debt / Equity (X), as of Mar 25, the value is 1.27. This value exceeds the healthy maximum of 1. It has increased from 1.16 (Mar 24) to 1.27, marking an increase of 0.11.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.68. It has increased from 0.48 (Mar 24) to 0.68, marking an increase of 0.20.
• For Current Ratio (X), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 1.5. It has decreased from 0.89 (Mar 24) to 0.74, marking a decrease of 0.15.
• For Quick Ratio (X), as of Mar 25, the value is 0.47. This value is below the healthy minimum of 1. It has decreased from 0.56 (Mar 24) to 0.47, marking a decrease of 0.09.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.67. This value is below the healthy minimum of 4. It has increased from 3.35 (Mar 24) to 3.67, marking an increase of 0.32.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 0.60. This value is below the healthy minimum of 3. It has decreased from 1.01 (Mar 24) to 0.60, marking a decrease of 0.41.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -0.33. This value is below the healthy minimum of 3. It has increased from -0.56 (Mar 24) to -0.33, marking an increase of 0.23.
• For Enterprise Value (Cr.), as of Mar 25, the value is 117.32. It has increased from 112.76 (Mar 24) to 117.32, marking an increase of 4.56.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.50. This value is within the healthy range. It has decreased from 2.22 (Mar 24) to 1.50, marking a decrease of 0.72.
• For EV / EBITDA (X), as of Mar 25, the value is 37.12. This value exceeds the healthy maximum of 15. It has increased from 36.70 (Mar 24) to 37.12, marking an increase of 0.42.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.84. This value is below the healthy minimum of 1. It has decreased from 1.21 (Mar 24) to 0.84, marking a decrease of 0.37.
• For Price / BV (X), as of Mar 25, the value is 1.48. This value is within the healthy range. It has increased from 1.39 (Mar 24) to 1.48, marking an increase of 0.09.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.84. This value is below the healthy minimum of 1. It has decreased from 1.21 (Mar 24) to 0.84, marking a decrease of 0.37.
• For EarningsYield, as of Mar 25, the value is -0.04. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded -0.04.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness